Allurion Technologies Announces 1-for-15 Reverse Stock Split to Aid Re-listing Efforts
Summary
Allurion Technologies announced a 1-for-15 reverse stock split, effective June 18, 2026, as part of its strategy to re-list on a national exchange after being delisted from the NYSE.
Key Events
-
1-for-15 Reverse Stock Split Approved
The Board's Pricing Committee approved a 1-for-15 reverse stock split, effective June 18, 2026, following stockholder authorization in December 2025.
-
Aimed at Re-listing on National Exchange
The split is intended to help the company regain compliance with NYSE or NYSE American listing requirements after its recent delisting and "going concern" warning.
-
Share Count and Derivative Adjustments
Outstanding common shares will decrease from approximately 15 million to 1 million. All outstanding equity awards, convertible notes, and warrants will be proportionally adjusted. Fractional shares will be rounded up.
Analysis
This reverse stock split is a critical step for Allurion Technologies as it attempts to regain compliance with national exchange listing requirements following its recent delisting from the NYSE and ongoing "going concern" issues. While reverse splits are often viewed negatively, this action is necessary for the company's strategy to improve its capital markets positioning and potentially access new funding, which is crucial for its survival.
At the time of this filing, ALURW was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $0.00 to $0.07. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.